A carregar...
Repurposing of SARS-CoV nucleocapsid protein specific nuclease resistant RNA aptamer for therapeutics against SARS-CoV-2
COVID-19 pandemic is rapidly advancing among human population. Development of new interventions including therapeutics and vaccines against SARS-CoV-2 will require time and validation before it could be made available for public use. Keeping in view of the emergent and evolving situation the motive...
Na minha lista:
| Publicado no: | Infect Genet Evol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier B.V.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7417262/ https://ncbi.nlm.nih.gov/pubmed/32791240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.meegid.2020.104497 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|